AbbVie (ABBV) Notes Payables (2016 - 2025)
Historic Notes Payables for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $3.8 billion.
- AbbVie's Notes Payables changed N/A to $3.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2022, which is 9285.71% down from last year.
- According to the latest figures from Q3 2025, AbbVie's Notes Payables is $3.8 billion.
- In the past 5 years, AbbVie's Notes Payables registered a high of $3.8 billion during Q3 2025, and its lowest value of $1.0 million during Q4 2022.
- For the 5-year period, AbbVie's Notes Payables averaged around $534.6 million, with its median value being $13.0 million (2021).
- Its Notes Payables has fluctuated over the past 5 years, first crashed by 9285.71% in 2022, then surged by 5300000.0% in 2025.
- AbbVie's Notes Payables (Quarter) stood at $14.0 million in 2021, then tumbled by 92.86% to $1.0 million in 2022, then skyrocketed by 100.0% to $2.0 million in 2023, then soared by 50.0% to $3.0 million in 2024, then skyrocketed by 126233.33% to $3.8 billion in 2025.
- Its Notes Payables was $3.8 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $1.6 billion in Q1 2025.